Page last updated: 2024-12-10

nicotine n-glucuronide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

nicotine N-glucuronide: a metabolite of nicotine [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

(S)-nicotinium N-alpha-D-glucosiduronate : An N-glycosylpyridine that is the N-alpha-D-glucosiduronyl derivative of (S)-nicotine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3035848
CHEBI ID63860
MeSH IDM0227611

Synonyms (22)

Synonym
nicotine-glucuronide
nicotine n-glucuronide
nicotine glucuronide
152306-59-7
(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[3-[(2s)-1-methylpyrrolidin-2-yl]pyridin-1-ium-1-yl]oxane-2-carboxylate
(s)-1-alpha-d-glucopyranuronosyl-3-(1-methyl-2-pyrrolidinyl)pyridinium inner salt
pyridinium, 1-alpha-d-glucopyranuronosyl-3-(1-methyl-2-pyrrolidinyl)-, inner salt, (s)-
1-(alpha-d-glucopyranuronosyl)-3-[(2s)-1-methylpyrrolidin-2-yl]pyridinium
(s)-nicotinium n-alpha-d-glucosiduronate
CHEBI:63860
3,4,5-trihydroxy-6-[5-(1-methylpyrrolidin-2-yl)pyridin-1-yl]-oxane-2-carboxylate
1-[(2s,3r,4s,5s,6s)-6-carboxylato-3,4,5-trihydroxyoxan-2-yl]-3-[(2s)-1-methylpyrrolidin-2-yl]-1$l^{5}-pyridin-1-ylium
1-alpha-delta-glucopyranuronosyl-3-[(2s)-1-methyl-2-pyrrolidinyl]-pyridinium
1-alpha-delta-glucopyranuronosyl-3-(1-methyl-2-pyrrolidinyl)-(s)-pyridinium
(s)-1-alpha-delta-glucopyranuronosyl-3-(1-methyl-2-pyrrolidinyl)pyridinium inner salt
(s)-1-alpha-delta-glucopyranuronosyl-3-(1-methyl-2-pyrrolidinyl)-pyridinium inner salt
(s)-1-alpha-d-glucopyranuronosyl-3-(1-methyl-2-pyrrolidinyl)-pyridinium inner salt
1-alpha-d-glucopyranuronosyl-3-[(2s)-1-methyl-2-pyrrolidinyl]-pyridinium
1-alpha-d-glucopyranuronosyl-3-(1-methyl-2-pyrrolidinyl)-(s)-pyridinium
1-hexopyranosyluronosyl-3-(1-methylpyrrolidin-2-yl)pyridin-1-ium
DTXSID50934467
Q27132866
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
N-glycosylpyridine
iminium betaine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (5)

PathwayProteinsCompounds
Nicotine Action Pathway3832
Nicotine Metabolism Pathway923
Nicotine Pathway, Pharmacokinetics129
Nicotine metabolism011
Nicotine metabolism in liver cells011

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (26.67)18.2507
2000's7 (46.67)29.6817
2010's3 (20.00)24.3611
2020's1 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (20.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]